Cargando…
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468217/ https://www.ncbi.nlm.nih.gov/pubmed/37616235 http://dx.doi.org/10.15585/mmwr.mm7234a4 |
| _version_ | 1785099191575379968 |
|---|---|
| author | Jones, Jefferson M. Fleming-Dutra, Katherine E. Prill, Mila M. Roper, Lauren E. Brooks, Oliver Sánchez, Pablo J. Kotton, Camille N. Mahon, Barbara E. Meyer, Sarah Long, Sarah S. McMorrow, Meredith L. |
| author_facet | Jones, Jefferson M. Fleming-Dutra, Katherine E. Prill, Mila M. Roper, Lauren E. Brooks, Oliver Sánchez, Pablo J. Kotton, Camille N. Mahon, Barbara E. Meyer, Sarah Long, Sarah S. McMorrow, Meredith L. |
| author_sort | Jones, Jefferson M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10468217 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104682172023-09-01 Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Jones, Jefferson M. Fleming-Dutra, Katherine E. Prill, Mila M. Roper, Lauren E. Brooks, Oliver Sánchez, Pablo J. Kotton, Camille N. Mahon, Barbara E. Meyer, Sarah Long, Sarah S. McMorrow, Meredith L. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2023-08-25 /pmc/articles/PMC10468217/ /pubmed/37616235 http://dx.doi.org/10.15585/mmwr.mm7234a4 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Jones, Jefferson M. Fleming-Dutra, Katherine E. Prill, Mila M. Roper, Lauren E. Brooks, Oliver Sánchez, Pablo J. Kotton, Camille N. Mahon, Barbara E. Meyer, Sarah Long, Sarah S. McMorrow, Meredith L. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 |
| title | Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 |
| title_full | Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 |
| title_fullStr | Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 |
| title_full_unstemmed | Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 |
| title_short | Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 |
| title_sort | use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices — united states, 2023 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468217/ https://www.ncbi.nlm.nih.gov/pubmed/37616235 http://dx.doi.org/10.15585/mmwr.mm7234a4 |
| work_keys_str_mv | AT jonesjeffersonm useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT flemingdutrakatherinee useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT prillmilam useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT roperlaurene useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT brooksoliver useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT sanchezpabloj useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT kottoncamillen useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT mahonbarbarae useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT meyersarah useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT longsarahs useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 AT mcmorrowmeredithl useofnirsevimabforthepreventionofrespiratorysyncytialvirusdiseaseamonginfantsandyoungchildrenrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstates2023 |